DE602005016537D1 - Testverfahren zur identifizierung eines kandidatenarzneistoffs - Google Patents
Testverfahren zur identifizierung eines kandidatenarzneistoffsInfo
- Publication number
- DE602005016537D1 DE602005016537D1 DE602005016537T DE602005016537T DE602005016537D1 DE 602005016537 D1 DE602005016537 D1 DE 602005016537D1 DE 602005016537 T DE602005016537 T DE 602005016537T DE 602005016537 T DE602005016537 T DE 602005016537T DE 602005016537 D1 DE602005016537 D1 DE 602005016537D1
- Authority
- DE
- Germany
- Prior art keywords
- soluble
- identifying
- oligopeptide
- polypeptide
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004107746 | 2004-03-31 | ||
PCT/JP2005/006728 WO2005095958A1 (ja) | 2004-03-31 | 2005-03-30 | 薬剤候補を同定するためのアッセイ法 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005016537D1 true DE602005016537D1 (de) | 2009-10-22 |
Family
ID=35063906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005016537T Active DE602005016537D1 (de) | 2004-03-31 | 2005-03-30 | Testverfahren zur identifizierung eines kandidatenarzneistoffs |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090087916A1 (de) |
EP (1) | EP1739425B1 (de) |
JP (1) | JPWO2005095958A1 (de) |
AT (1) | ATE442588T1 (de) |
DE (1) | DE602005016537D1 (de) |
WO (1) | WO2005095958A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103735554B (zh) | 2006-03-29 | 2018-03-20 | 维斯塔实验室有限公司 | 蛋白聚集抑制剂 |
WO2011017319A1 (en) | 2009-08-03 | 2011-02-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods of treating disorders associated with protein polymerization |
US8809617B2 (en) * | 2009-11-05 | 2014-08-19 | The University of Pittsburgh—Of the Commonwealth System of Higher Education | Automated high-content live animal drug screening using C. elegans |
US9072772B2 (en) | 2009-11-05 | 2015-07-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | Methods of treating disorders associated with protein aggregation |
CN114106141A (zh) * | 2021-12-13 | 2022-03-01 | 中国科学院深圳先进技术研究院 | 一种β-淀粉样蛋白聚合物的制备方法及其产品和应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0667959B1 (de) | 1992-10-26 | 2003-08-13 | Elan Pharmaceuticals, Inc. | Verfahren zur Identifizierung von Hemmstoffe der Produktion des beta-Amyloidpeptids |
EP1071943A4 (de) * | 1998-04-14 | 2005-08-10 | Univ California | Test zum nachweis von mikrotubulus depolymerisierungshemmern |
GB2348203B (en) | 1998-11-04 | 2002-06-19 | Imp College Innovations Ltd | Solube beta-forms of prion proteins, methods of preparation and use |
EP1140973A4 (de) * | 1998-12-22 | 2002-10-30 | Myriad Genetics Inc | Protein-protein wechselwirkungen in neurodegenerativen erkrankungen |
CA2361013A1 (en) | 1999-01-25 | 2000-07-27 | Minerva Biotechnologies Corporation | Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases |
US20030083277A1 (en) | 2000-02-24 | 2003-05-01 | Hersh Louis B. | Use of insulin degrading enzyme (IDE) for the treatment of alzheimer's disease in patients |
US20030027210A1 (en) * | 2001-01-03 | 2003-02-06 | Daniel Benjamin | Alpha synuclein aggregation assays |
GB0100119D0 (en) * | 2001-01-03 | 2001-02-14 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
US6626963B2 (en) * | 2001-09-21 | 2003-09-30 | E. I. Du Pont De Nemours And Company | Process for restoring the appearance of pigmented or dyed para-aramid fabric |
JP3699046B2 (ja) * | 2002-01-09 | 2005-09-28 | 株式会社日立メディコ | 超音波治療装置 |
JP4334819B2 (ja) * | 2002-05-17 | 2009-09-30 | 株式会社日立メディコ | 血栓検出装置及び血栓治療装置 |
JP2005533042A (ja) | 2002-06-10 | 2005-11-04 | オクラホマ メディカル リサーチ ファウンデーション | 中枢神経系の炎症状態の治療において連結ビス(ポリヒドロキシフェニル)およびそのo−アルキル誘導体を使用するための方法 |
-
2005
- 2005-03-30 EP EP05728425A patent/EP1739425B1/de not_active Not-in-force
- 2005-03-30 JP JP2006511880A patent/JPWO2005095958A1/ja active Pending
- 2005-03-30 WO PCT/JP2005/006728 patent/WO2005095958A1/ja active Application Filing
- 2005-03-30 US US10/594,927 patent/US20090087916A1/en not_active Abandoned
- 2005-03-30 AT AT05728425T patent/ATE442588T1/de not_active IP Right Cessation
- 2005-03-30 DE DE602005016537T patent/DE602005016537D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
EP1739425A1 (de) | 2007-01-03 |
ATE442588T1 (de) | 2009-09-15 |
US20090087916A1 (en) | 2009-04-02 |
WO2005095958A1 (ja) | 2005-10-13 |
EP1739425B1 (de) | 2009-09-09 |
JPWO2005095958A1 (ja) | 2008-02-21 |
EP1739425A4 (de) | 2008-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60320867D1 (de) | Verfahren und vorrichtung zur charakterisierung von analyten | |
ATE442588T1 (de) | Testverfahren zur identifizierung eines kandidatenarzneistoffs | |
ATE470864T1 (de) | Verfahren zur quantifizierung von allergenen | |
ATE537448T1 (de) | Nachweis von rho-proteinen | |
DE602005021614D1 (de) | Gegenionenaustauschverfahren für peptide | |
NO20011386D0 (no) | Nye metoder for fremvisning av (poly)peptider/proteiner pÕ bakteriofage partikler via disulfidbindinger | |
DE602004022575D1 (de) | Verfahren zum selektiven testen von adiponectinmultimeren | |
ATE441102T1 (de) | Verfahren zur detektion von intrazellulären parametern mit lumineszierenden proteinsonden zur selektion von molekülen, die diese parameter ändern kínnen | |
DE602006006855D1 (de) | Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb) | |
ATE468537T1 (de) | Neurodegenerative marker für depression. | |
DK1755634T3 (da) | Oligopeptider til formindskelse af forhöjet blodurinstofkoncentration | |
BRPI0616712B8 (pt) | método para amidar polipeptídeos com terminais c de aminoácido básicos por meio de endoproteases específicas | |
MX2021011726A (es) | Escindasas modificadas, usos de las mismas y kits relacionados. | |
ATE483981T1 (de) | Verfahren, zusammensetzungen und verbindungstests zur hemmung der amyloid-beta-proteinproduktion | |
ATE548463T1 (de) | Lrrk2 polypeptidesubstrate und ihre verwendungen | |
Gazdik et al. | The effect of N-methylation on transition state mimetic inhibitors of the Plasmodium protease, plasmepsin V | |
Marcelo Der Torossian et al. | Highly potential antiplasmodial restricted peptides | |
Domin et al. | Neuropeptide Y and its C-terminal fragments acting on Y2 receptor: Raman and SERS spectroscopy studies | |
Karhu et al. | Isolation of new ligands for orphan receptor MRGPRX1—hemorphins LVV-H7 and VV-H7 | |
Ellis‐Steinborner et al. | An unusual kynurenine‐containing opioid tetrapeptide from the skin gland secretion of the Australian red tree frog Litoria rubella. Sequence determination by electrospray mass spectrometry | |
WO2006089801A3 (de) | Verfahren zum redox-potential-abhängigen nachweis von targetmolekülen durch wechselwirkende polypeptide | |
DE602005026525D1 (de) | Verfahren zur bestimmung eines gewebeabbauverfahrens durch nachweis von comp-neoepitopen | |
ATE438100T1 (de) | Verfahren zum funktionellen nachweis von masps und dessen komplexen | |
ATE434792T1 (de) | Verfahren zur konformationsanalyse von aminosäuresequenzen | |
ATE389182T1 (de) | Prion-assays mit hoher durchlaufleistung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |